A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 14, 2024

Primary Completion Date

January 16, 2025

Study Completion Date

March 6, 2025

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

3mg TQC3721 Suspension for Inhalation

TQC3721 suspension for inhalation is target inhibitor.

DRUG

6mg TQC3721 Suspension for Inhalation

TQC3721 suspension for inhalation is target inhibitor.

DRUG

Placebo TQC3721 suspension for inhalation

Placebo without active drug substance.

Trial Locations (28)

20025

Shanghai JiaoTong University of medicine Ruijin Hospital, Shanghai

61012

Cangzhou Hospital of Integrated Tcm-Wm·Hebei, Cangzhou

100007

Genertec Liaoyou Gem Flower Hospital, Panjin

130031

The First Hospital of Jilin University, Changchun

136099

Siping Central People's Hospital, Siping

214000

Wuxi Fifth People's Hospital, Wuxi

214200

Yixing People'S Hospital, Wuxi

225000

Northern Jiangsu People's Hospital, Yangzhou

236000

Fu Yang People'S Hospital, Fuyang

274031

Heze Municipal Hospital, Heze

300041

Tianjin Medical University General Hospital, Tianjin

300142

TianJin 4th Center Hospital, Tianjin

325027

Wenzhou University Affiliated Second Hospital, Wenzhou

330006

Jiangxi Provincial People's Hospital, Nanchang

361021

The Second Affiliated Hospital of Xiamen Medical College, Xiamen

400000

ChongQing University Fuling Hospital, Chongqing

457001

Puyang Oilfield General Hospital, Puyang

476000

Shangqiu First People's Hospita, Shangqiu

510120

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

530016

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

563000

Zunyi Medical University Affiliated Hospital, Zunyi

610044

West China Hospital of Sichuan University, Chengdu

629000

Suining Central Hospital, Suining

730000

The First Hospital of Lanzhou University, Lanzhou

832000

The First Affiliated Hospital of Shihezi University, Shihezi

050051

The Third Hospital of Hebei Medical University, Shijiazhuang

024000

Chifeng Municipal Hospital, Chifeng

030000

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY